Axalta
AXTA · Specialty Chemicals
$34.14
2.6%Solstice Advanced Materials
SOLS · Specialty Chemicals
$59.42
0.6%The short version
- Axalta is the larger business, with $5.1B of revenue in fiscal 2025 against $3.9B for Solstice Advanced Materials.
- Solstice Advanced Materials grew revenue faster (3.1%, against −3.0%).
- Axalta turned more of its sales into free cash flow (8.9% FCF margin, against 3.1% FCF margin).
- Solstice Advanced Materials earned a higher return on the capital invested in it (12.2%, against 10.5%).
- Investors pay more for each dollar of Solstice Advanced Materials’s earnings: a P/E of 39.9x against 20.0x for Axalta.
| Latest fiscal year | AXTA · FY25 | SOLS · FY25 |
|---|---|---|
| Size | ||
| Market cap | $7.3B | $9.5B |
| Revenue | $5.1B | $3.9B |
| Free cash flow | $453M | $119M |
| Net income | $378M | $237M |
| Growth | ||
| Revenue growth | −3.0% | 3.1% |
| 5-year growth | 6.5% | — |
| Share count change | −1.5% | 0.1% |
| Profitability | ||
| Gross margin | 34.4% | 32.2% |
| Operating margin | 14.4% | — |
| Net margin | 7.4% | 6.1% |
| FCF margin | 8.9% | 3.1% |
| Return on capital | 10.5% | 12.2% |
| Return on equity | 17.8% | 10.2% |
| Balance sheet | ||
| Net debt | $2.5B | $1.6B |
| Net debt / EBITDA | 2.5x | 2.3x |
| Dividends and buybacks | $165M | $1.5B |
| Valuation & quality | ||
| P/E | 20.0x | 39.9x |
| Piotroski F-score | 7 | — |
FY16
AXTA $4.1B
SOLS —
FY17
AXTA $4.4B
SOLS —
FY18
AXTA $4.7B
SOLS —
FY19
AXTA $4.5B
SOLS —
FY20
AXTA $3.7B
SOLS —
FY21
AXTA $4.4B
SOLS —
FY22
AXTA $4.9B
SOLS —
FY23
AXTA $5.2B
SOLS $3.6B
FY24
AXTA $5.3B
SOLS $3.8B
FY25
AXTA $5.1B
SOLS $3.9B
AXTA
SOLS
FY16
AXTA 9.9%
SOLS —
FY17
AXTA 8.3%
SOLS —
FY18
AXTA 9.4%
SOLS —
FY19
AXTA 10.9%
SOLS —
FY20
AXTA 8.2%
SOLS —
FY21
AXTA 10.5%
SOLS —
FY22
AXTA 8.7%
SOLS —
FY23
AXTA 11.3%
SOLS —
FY24
AXTA 13.4%
SOLS —
FY25
AXTA 14.4%
SOLS —
AXTA
SOLS
FY16
AXTA $423M
SOLS —
FY17
AXTA $415M
SOLS —
FY18
AXTA $353M
SOLS —
FY19
AXTA $461M
SOLS —
FY20
AXTA $427M
SOLS —
FY21
AXTA $437M
SOLS —
FY22
AXTA $143M
SOLS —
FY23
AXTA $437M
SOLS $461M
FY24
AXTA $436M
SOLS $546M
FY25
AXTA $453M
SOLS $119M
AXTA
SOLS
FY16
AXTA 5.4%
SOLS —
FY17
AXTA 4.2%
SOLS —
FY18
AXTA 7.7%
SOLS —
FY19
AXTA 8.4%
SOLS —
FY20
AXTA 7.3%
SOLS —
FY21
AXTA 8.3%
SOLS —
FY22
AXTA 6.8%
SOLS —
FY23
AXTA 9.8%
SOLS —
FY24
AXTA 11.9%
SOLS —
FY25
AXTA 10.5%
SOLS 12.2%
AXTA
SOLS
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.